Association of CLU gene polymorphism with Parkinson's disease in the Chinese Han population
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of
CLU
gene polymorphism with Parkinson's disease in the Chinese Han population
Authors
Keywords
-
Journal
JOURNAL OF GENE MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-10
DOI
10.1002/jgm.3302
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
- (2020) Kathy Dujardin et al. Frontiers in Neuroscience
- Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
- (2019) Evangeline M. Foster et al. Frontiers in Neuroscience
- Central Nervous System-Derived Exosomal Alpha-Synuclein in Serum May Be a Biomarker in Parkinson’s Disease
- (2019) Xiaoli Si et al. NEUROSCIENCE
- Resveratrol, an activator of SIRT1, improves ER stress by increasing clusterin expression in HepG2 cells
- (2019) Jinmi Lee et al. CELL STRESS & CHAPERONES
- Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson’s Disease Models
- (2019) Hefeng Zhou et al. Neurotherapeutics
- [PROVISIONAL] The combined risk effect among BIN1, CLU and APOE genes in Alzheimer’s disease
- (2019) Lígia Ramos dos Santos et al. GENETICS AND MOLECULAR BIOLOGY
- The genetic architecture of Parkinson's disease
- (2019) Cornelis Blauwendraat et al. LANCET NEUROLOGY
- Gene-by-environment interactions in Alzheimer’s disease and Parkinson’s disease
- (2019) Amy R. Dunn et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Clusterin as a potential marker of brain ischemia-reperfusion injury in patients undergoing carotid endarterectomy
- (2019) Joanna Iłżecka et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease
- (2019) Shirley Yin-Yu Pang et al. Translational Neurodegeneration
- Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson’s disease
- (2019) Milos Stanojlovic et al. Molecular Brain
- Brain clusterin protein isoforms and mitochondrial localization
- (2019) Sarah K Herring et al. eLife
- Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals
- (2018) Liv Tybjærg Nordestgaard et al. BMC Medicine
- Clusterin, a novel DEC1 target, modulates DNA damage-mediated cell death
- (2018) Xin Ming et al. MOLECULAR CANCER RESEARCH
- Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers
- (2018) Daniel R. Whiten et al. Cell Reports
- Alpha-synuclein deregulates the expression of COL4A2 and impairs ER-Golgi function
- (2018) Isabel Paiva et al. NEUROBIOLOGY OF DISEASE
- rs3851179 Polymorphism at 5′ to the PICALM Gene is Associated with Alzheimer and Parkinson Diseases in Brazilian Population
- (2017) Cíntia Barros Santos-Rebouças et al. NEUROMOLECULAR MEDICINE
- On the Role of Mining Exposure in Epigenetic Effects in Parkinson’s Disease
- (2017) Sebastian Castillo et al. NEUROTOXICITY RESEARCH
- Epidemiology, environmental risk factors and genetics of Parkinson's disease
- (2017) Anna Delamarre et al. PRESSE MEDICALE
- Clusterin protects neurons against intracellular proteotoxicity
- (2017) Jenna M. Gregory et al. Acta Neuropathologica Communications
- Clusterin CSF levels in differential diagnosis of neurodegenerative disorders
- (2016) Hana Přikrylová Vranová et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Tau protein, beta-amyloid1–42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia
- (2014) Hana Přikrylová Vranová et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Molecular chaperones and proteostasis regulation during redox imbalance
- (2014) Katerina Niforou et al. Redox Biology
- The Molecular Chaperone Apolipoprotein J/Clusterin as a Sensor of Oxidative Stress: Implications in Therapeutic Approaches - A Mini-Review
- (2013) Ioannis P. Trougakos GERONTOLOGY
- Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population
- (2013) Sun Ju Chung et al. NEUROBIOLOGY OF AGING
- Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease
- (2013) Karin D. van Dijk et al. PARKINSONISM & RELATED DISORDERS
- Quantification of clusterin in paired cerebrospinal fluid and plasma samples
- (2013) W. Jongbloed et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study
- (2012) Urban Ekman et al. LANCET NEUROLOGY
- An Exploratory Study on CLU, CR1 and PICALM and Parkinson Disease
- (2011) Jianjun Gao et al. PLoS One
- CSF markers of neurodegeneration in Parkinson’s disease
- (2010) Hana Přikrylová Vranová et al. JOURNAL OF NEURAL TRANSMISSION
- Transcriptional and posttranslational regulation of clusterin by the two main cellular proteolytic pathways
- (2009) Eirini Balantinou et al. FREE RADICAL BIOLOGY AND MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started